Biology of Chronic Myeloid Leukemia and Possible Therapeutic Approaches to Imatinib-Resistant Disease

スポンサーリンク

概要

• 論文の詳細を見る
• 2004-06-15

著者

• Yoshida Chikashi

  Department Of Haematology Imperial College London Hammersmith Hospital

• MELO Junia

  Department of Haematology, Imperial College London, Hammersmith Hospital

• Melo Junia

  Department Of Haematology Imperial College London Hammersmith Hospital

関連論文

• Biology of Chronic Myeloid Leukemia and Possible Therapeutic Approaches to Imatinib-Resistant Disease
• Adherence to the standard dose of imatinib, rather than dose adjustment based on its plasma concentration, is critical to achieve a deep molecular response in patients with chronic myeloid leukemia
• Harmonization of molecular monitoring of chronic myeloid leukemia therapy in Japan

スポンサーリンク